PEGylated Erlotinib HCl Injectable Nanoformulation for Improved Bioavailability
Crossref DOI link: https://doi.org/10.1208/s12249-023-02560-5
Published Online: 2023-04-10
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Bhargave, Hardik
Nijhawan, Harsh
Yadav, Khushwant S. http://orcid.org/0000-0002-1620-0547
Text and Data Mining valid from 2023-04-10
Version of Record valid from 2023-04-10
Article History
Received: 22 June 2022
Accepted: 27 March 2023
First Online: 10 April 2023
Declarations
:
: The authors declare no competing interests.